NEW YORK ( TheStreet) -- CHANGE IN RATINGS Alcoa ( AA) was downgraded at Deutsche Bank to sell from hold. $5.50 price target. Boom times are long gone in the metals business, Deutsche Bank said. Aptargroup ( ATR) was downgraded at J.P. Morgan to neutral from overweight. $65 price target. Macro upside lever more limited, J.P. Morgan said. Baxter ( BAX) was downgraded at Credit Suisse to neutral from outperform. $73 price target. Outlook for hemophilia market remains uncertain, Credit Suisse said. BBX Capital ( BBX) was upgraded to hold at TheStreet Ratings. Cabela's ( CAB) was initiated with a market perform rating at William Blair. Company has uncertain near-term sales trends, William Blair said. CNH) was downgraded to hold at TheStreet Ratings. Hologic ( HOLX) was initiated with a buy rating at Needham. $26 price target. Company can post modest sales growth, against easier comps, Needham said. Manpower ( MAN) was upgraded at Bank of America/Merrill Lynch to buy. $85 price target. Company should see a better macro environment and is cutting costs, BofA/Merrill said. Resmed ( RMD) was downgraded at UBS to neutral from buy. Valuation call, based on a $50.50 price target, UBS said. STX) was upgraded at Pacific Crest to outperform from sector perform. $53 price target. Market is overly concerned about PC demand and market share loss to flash, Pacific Crest said. Tesla ( TSLA) was downgraded at Robert Baird to neutral from outperform. Valuation call, Baird said.